Compile Data Set for Download or QSAR
Report error Found 356 with Last Name = 'okamoto' and Initial = 't'
TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610688(US10626095, Example 1)
Affinity DataEC50:  500nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610689(US10626095, Example 2)
Affinity DataEC50:  280nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610690(US10626095, Example 3)
Affinity DataEC50:  260nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610691(US10626095, Example 4)
Affinity DataEC50:  240nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610692(US10626095, Example 5)
Affinity DataEC50:  200nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610693(US10626095, Example 6)
Affinity DataEC50:  400nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610694(US10626095, Example 7)
Affinity DataEC50:  170nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610696(US10626095, Example 8)
Affinity DataEC50:  290nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610697(US10626095, Example 9)
Affinity DataEC50:  230nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610698(US10626095, Example 10)
Affinity DataEC50:  70nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610699(US10626095, Example 11)
Affinity DataEC50:  670nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610700(US10626095, Example 12)
Affinity DataEC50:  690nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610701(US10626095, Example 13)
Affinity DataEC50:  870nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610702(US10626095, Example 14)
Affinity DataEC50:  500nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610703(US10626095, Example 15)
Affinity DataEC50:  490nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610704(US10626095, Example 16)
Affinity DataEC50:  670nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610705(US10626095, Example 17)
Affinity DataEC50:  520nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610706(US10626095, Example 18)
Affinity DataEC50:  570nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610707(US10626095, Example 19)
Affinity DataEC50:  530nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610708(US10626095, Example 20)
Affinity DataEC50:  1.62E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610709(US10626095, Example 21)
Affinity DataEC50:  770nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610710(US10626095, Example 22)
Affinity DataEC50:  650nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610711(US10626095, Example 23)
Affinity DataEC50:  450nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610712(US10626095, Example 24)
Affinity DataEC50:  0nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610713(US10626095, Example 25)
Affinity DataEC50:  540nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610714(US10626095, Example 26)
Affinity DataEC50:  690nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610715(US10626095, Example 27)
Affinity DataEC50:  890nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610716(US10626095, Example 28)
Affinity DataEC50:  370nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610717(US10626095, Example 29)
Affinity DataEC50:  680nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610718(US10626095, Example 30)
Affinity DataEC50:  640nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610719(US10626095, Example 31)
Affinity DataEC50:  380nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610720(US10626095, Example 32)
Affinity DataEC50:  740nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610721(US10626095, Example 33)
Affinity DataEC50:  270nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610722(US10626095, Example 34)
Affinity DataEC50:  460nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610723(US10626095, Example 35)
Affinity DataEC50:  340nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610724(US10626095, Example 36)
Affinity DataEC50:  450nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610725(US10626095, Example 37)
Affinity DataEC50:  120nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610726(US10626095, Example 38)
Affinity DataEC50:  420nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610727(US10626095, Example 39)
Affinity DataEC50:  710nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610728(US10626095, Example 40)
Affinity DataEC50:  550nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610729(US10626095, Example 41)
Affinity DataEC50:  390nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610730(US10626095, Example 42)
Affinity DataEC50:  590nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610731(US10626095, Example 43)
Affinity DataEC50:  670nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610732(US10626095, Example 44)
Affinity DataEC50:  690nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610733(US10626095, Example 45)
Affinity DataEC50:  910nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610734(US10626095, Example 46)
Affinity DataEC50:  980nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610736(US10626095, Example 47)
Affinity DataEC50:  1.07E+3nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610737(US10626095, Example 48)
Affinity DataEC50:  430nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610738(US10626095, Example 49)
Affinity DataEC50:  480nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetSolute carrier family 13 member 5(Human)
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM610739(US10626095, Example 50)
Affinity DataEC50:  440nMAssay Description:NaCT-CHO and pME-CHO were plated at 20,000 cells/well into white CulturPlate -96 (PerkinElmer) two days before the assay. Prior to assay incubation, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

Displayed 1 to 50 (of 356 total ) | Next | Last >>
Jump to: